Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pittrow

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
ERJ Open Research|December 10, 2025
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat <i>versus</i> other medications: a COMPERA analysisMatthias Held, Christine Pausch, Doerte Huscher, et al.
International Journal of Cardiology|January 7, 2012
Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011H Ardeschir Ghofrani, Oliver Distler, Felix Gerhardt, et al.
The European Respiratory Journal|May 9, 2020
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registryJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Cardiovascular Diagnosis and Therapy|February 12, 2019
Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part I: development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmiaRhoia Neidenbach, Koichiro Niwa, Oeztekin Oto, et al.
Cardiovascular Diagnosis and Therapy|February 12, 2019
Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathyRhoia Neidenbach, Koichiro Niwa, Oeztekin Oto, et al.
Respiratory Research|March 17, 2019
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
Respiratory Research|July 16, 2017
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
The European Respiratory Journal|April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registryJürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
ERJ Open Research|December 10, 2025
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat <i>versus</i> other medications: a COMPERA analysisMatthias Held, Christine Pausch, Doerte Huscher, et al.
International Journal of Cardiology|January 7, 2012
Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011H Ardeschir Ghofrani, Oliver Distler, Felix Gerhardt, et al.
The European Respiratory Journal|May 9, 2020
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registryJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Cardiovascular Diagnosis and Therapy|February 12, 2019
Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part I: development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmiaRhoia Neidenbach, Koichiro Niwa, Oeztekin Oto, et al.
Cardiovascular Diagnosis and Therapy|February 12, 2019
Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathyRhoia Neidenbach, Koichiro Niwa, Oeztekin Oto, et al.
Respiratory Research|March 17, 2019
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
Respiratory Research|July 16, 2017
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
The European Respiratory Journal|April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registryJürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
Pageof 15